Lifeway Foods, Inc. produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types, including low fat, non-fat, whole milk, protein, and BioKefir. The company also offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; cupped kefir and Icelandic Skyr, a line of strained kefir and yogurt products; and frozen kefir in soft serve and pint-size containers. It sells its products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers primarily through direct sales force, brokers, and distributors. The company was founded in 1986 and is based in Morton Grove, Illinois.
IPO Year:
Exchange: NASDAQ
Website: lifewaykefir.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/24/2024 | Outperform → Market Perform | Noble Capital Markets | |
| 5/30/2024 | $20.00 | Market Perform → Outperform | Noble Capital Markets |
| 4/5/2024 | $25.00 | Buy | Lake Street |
| 3/27/2024 | Outperform → Market Perform | Noble Capital Markets | |
| 2/26/2024 | $14.00 | Market Perform → Outperform | Noble Capital Markets |
| 11/27/2023 | Outperform → Market Perform | Noble Capital Markets | |
| 11/14/2023 | $13.00 | Market Perform → Outperform | Noble Capital Markets |
| 9/25/2023 | Outperform → Market Perform | Noble Capital Markets | |
| 11/16/2022 | $10.00 | Market Perform → Outperform | Noble Capital Markets |
8-K - Lifeway Foods, Inc. (0000814586) (Filer)
8-K - Lifeway Foods, Inc. (0000814586) (Filer)
8-K - Lifeway Foods, Inc. (0000814586) (Filer)
8-K/A - Lifeway Foods, Inc. (0000814586) (Filer)
8-K - Lifeway Foods, Inc. (0000814586) (Filer)
10-Q - Lifeway Foods, Inc. (0000814586) (Filer)
8-K - Lifeway Foods, Inc. (0000814586) (Filer)
8-A12B - Lifeway Foods, Inc. (0000814586) (Filer)
10-Q - Lifeway Foods, Inc. (0000814586) (Filer)
8-K - Lifeway Foods, Inc. (0000814586) (Filer)
Event coincides with recently announced projections for record Q4 2024 and Full Year 2024 net sales MORTON GROVE, Ill., Jan. 30, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY), the leading U.S. supplier of kefir and fermented probiotic products, will ring the closing bell at the Nasdaq MarketSite in Times Square, New York City on Monday, February 3, 2025. The company previously announced unaudited preliminary fourth quarter net sales between $45.1 million to $46.6 million and full year 2024 preliminary unaudited net sales projected to range between $185.0 million and $186.5 million compared to $160.1 million in 2023. These results as well as business and philanthropic milestones unde
Company also announces unaudited preliminary fourth quarter net sales between $45.1 million to $46.6 millionFull year 2024 preliminary unaudited net sales are projected to range between $185.0 million and $186.5 million compared to $160.1 million in 2023MORTON GROVE, Ill., Jan. 6, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced that its Board of Directors (the "Board") has responded to the December 30, 2024 letter sent to Lifeway by Danone North America PBC ("Danone") reaffirming that the Company rejected Danone's offer to acquire the Company becau
MORTON GROVE, Ill., Nov. 26, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) (the "Company" or "Lifeway"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today provided additional information regarding the reasons that its Board of Directors rejected the revised unsolicited proposal made on November 15, 2024 by Danone North America PBC ("Danone") to acquire all the shares of Lifeway that it does not already own for $27.00 per share. The Board determined that Danone's $27.00 per share proposal substantially undervalues the
CHICAGO, Nov. 22, 2024 /PRNewswire/ -- Edward and Ludmila Smolyansky ("Founding Shareholders"), who together exercise voting control with respect to approximately 29.7% of the outstanding shares of common stock of Lifeway Foods, Inc. (NASDAQ:LWAY), today called for Lifeway's board of directors to take several actions, including immediately establishing an independent special committee to evaluate and negotiate a transaction with Danone or other potential buyers. This follows a proposal by Danone North America PBC to acquire all outstanding shares of Lifeway that Danone does not already own for $27 per share in cash. Rather than negotiate with Danone in response to its generous proposal, Lif
Leading U.S. Kefir Brand Announces Functional Beverage Made with Kefir Cultures to Support Skin Health, Immune System and the Microbiome MORTON GROVE, Ill., Nov. 20, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, has announced its latest functional beverage innovation: Probiotic Smoothie + Collagen made with kefir cultures. Available in four delicious flavors – Matcha Latte, Berry Blast, Tropical Fruit, and Plain – the new line features 5 grams of collagen in each serving and is lactose-free, as consumer demand for lactose-free dairy products is predicted to grow rapidly over the next five y
MORTON GROVE, Ill., Nov. 20, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) (the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced that its Board of Directors has rejected the revised unsolicited proposal made on November 15, 2024 by Danone North America PBC ("Danone") to acquire all the shares of Lifeway that it does not already own for $27.00 per share. After careful and thorough consideration, conducted in consultation with its independent financial and legal advisors, the Board determined that D
MORTON GROVE, Ill., Nov. 15, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, confirmed that it has received a revised, unsolicited, non-binding proposal from Danone North America PBC ("Danone") to acquire all outstanding shares of common stock of Lifeway it does not already own for $27.00 per share in cash. According to the Schedule 13D amendment filed today with the U.S. Securities and Exchange Commission disclosing the revised proposal, Danone beneficially owns approximately 23.3% of Lifeway's outstanding common stock.
Year-to-date net sales of $139.9 million; up 18.5% year-over-year Heightened interest in probiotic foods with bioavailable nutrients drives volume growth of Lifeway Kefir and Farmer Cheese 20th consecutive quarter of year-over-year growth Year-to-date gross profit margin increased to 26.2% MORTON GROVE, Ill., Nov. 14, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today reported financial results for the third quarter ended September 30, 2024. "I
MORTON GROVE, Ill., Nov. 8, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the third quarter ended September 30, 2024 on November 14, 2024 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details will be made available through the "Investor Relations" sectio
CHICAGO, Nov. 7, 2024 /PRNewswire/ -- On September 23, 2024, Danone SA (OTCQX:DANOY) proposed to acquire Lifeway Foods (NASDAQ:LWAY) in a transaction valued at approximately $283 million, offering $25 per share in cash. However, on November 6, the Lifeway Foods Board of Directors rejected the offer, instead adopting a "poison pill" limited shareholder rights plan. Edward and Ludmila Smolyansky, significant shareholders and members of Lifeway Foods' founding family, released the following statement in response: "For nearly four decades, we have fostered Lifeway's growth with careful attention to what is best for the company's future. Today, we strongly support Danone's offer, which represent
Noble Capital Markets downgraded Lifeway Foods from Outperform to Market Perform
Noble Capital Markets upgraded Lifeway Foods from Market Perform to Outperform and set a new price target of $20.00
Lake Street initiated coverage of Lifeway Foods with a rating of Buy and set a new price target of $25.00
Noble Capital Markets downgraded Lifeway Foods from Outperform to Market Perform
Noble Capital Markets upgraded Lifeway Foods from Market Perform to Outperform and set a new price target of $14.00
Noble Capital Markets downgraded Lifeway Foods from Outperform to Market Perform
Noble Capital Markets upgraded Lifeway Foods from Market Perform to Outperform and set a new price target of $13.00
Noble Capital Markets downgraded Lifeway Foods from Outperform to Market Perform
Noble Capital Markets upgraded Lifeway Foods from Market Perform to Outperform and set a new price target of $10.00
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
Year-to-date net sales of $139.9 million; up 18.5% year-over-year Heightened interest in probiotic foods with bioavailable nutrients drives volume growth of Lifeway Kefir and Farmer Cheese 20th consecutive quarter of year-over-year growth Year-to-date gross profit margin increased to 26.2% MORTON GROVE, Ill., Nov. 14, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today reported financial results for the third quarter ended September 30, 2024. "I
MORTON GROVE, Ill., Nov. 8, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the third quarter ended September 30, 2024 on November 14, 2024 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details will be made available through the "Investor Relations" sectio
MORTON GROVE, Ill., Nov. 5, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced that its Board of Directors (the "Board") has rejected the unsolicited proposal made on September 23, 2024 by Danone North America PBC ("Danone") to acquire all the shares of Lifeway that it does not already own for $25.00 per share. After careful and thorough consideration, conducted in consultation with its independent financial and legal advisors, the Boar
Demand for Bioavailable Foods like Kefir Soars Net sales of $49.2 million; up 25.3% year-over-year driven by volume growth of Lifeway Kefir 19th consecutive quarter of year-over-year growth MORTON GROVE, Ill., Aug. 13, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today reported financial results for the second quarter ended June 30, 2024. "Our incredible momentum continued in the second quarter as we delivered our 19th consecutive quarter of net
MORTON GROVE, Ill., Aug. 6, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the second quarter ended June 30, 2024 on August 13, 2024 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details will be made available through the "Investor Relations" section of t
Net sales of $44.6 million; up 17.8% year-over-year driven by volume growth of Lifeway Kefir 18th consecutive quarter of year-over-year growth Delivers 410 basis points of gross profit margin expansion MORTON GROVE, Ill., May 14, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today reported financial results for the first quarter ended March 31, 2024. "Following our tremendous results in 2023, I am thrilled to report yet another record-breaking qua
MORTON GROVE, Ill., May 7, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the first quarter ended March 31, 2024 on May 14, 2024 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details will be made available through the "Investor Relations" section of the C
Record annual net sales of $160.1 million; up 13.1% year-over-year 17th consecutive quarter of year-over-year growth Delivers 760 basis points of annual gross profit margin expansion MORTON GROVE, Ill., March 20, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today reported financial results for the fourth quarter and full year ended December 31, 2023. "I am pleased to report another outstanding year for Lifeway Foods, highlighted by our record-bre
MORTON GROVE, Ill., March 13, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the fourth quarter and full year ended December 31, 2023 on March 20, 2024 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details will be made available through the "Investor Rela
Net sales increase 7.2% year-over-year to $40.9 million; 16th consecutive quarter of year-over-year net sales growth 730 basis points of year-over-year gross profit margin expansion MORTON GROVE, Ill., Nov. 13, 2023 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today reported financial results for the third quarter ended September 30, 2023. "I am excited to announce that our strong momentum continued in the third quarter as we once again set a Company
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)